EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non‐SMC condensin I complex subunit H participates in anti‐programmed cell death‐1 resistance of clear cell renal cell carcinomas

Zhi Chen, Weiqiang Ruan, Chunhao Guo, Ke Chen, Le Li, Jihua Tian, Zhiquan Hu, Dan Peng, Xing Zeng iD

Cell Proliferation · 2023

DOI: 10.1111/cpr.13400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, 2023. Verfasst von Zhi Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‐SMC condensin I complex subunit H (NCAPH) is reported to play an important role and be a poor prognostic factor in various cancers. However, the function and regulatory mechanism of NCAPH in clear cell renal cell carcinoma (ccRCC) remain unknown. The roles of NCAPH on ccRCC growth were detected in vitro and in vivo assays. The regulatory mechanism of NCAPH was explored by immunoprecipitation assay, ubiquitination assay, ChIP assay, RIP assay, luciferase reporter assay and RNA pull‐down assay. The role of NCAPH in immunoregulation also was explored by flow cytometry, T cell‐mediated tumour cell killing assay and immune‐competent mouse model. In this research, we displayed that NCAPH was upregulated in ccRCC and patients with elevated NCAPH expression had an undesirable prognosis. Functionally, NCAPH depletion restrained ccRCC growth in vitro and in vivo. The elevated NCAPH was attributed to FOXP3‐mediated transcription, FUS‐mediated transcription splicing and METTL3‐mediated m6A modification. Moreover, YTHDC1 promoted NCAPH mRNA nuclear export, and IGF2BP3 enhanced NCAPH mRNA stability in an m6A‐dependent manner. NCAPH increased PD‐L1 expression by inhibiting the degradation of β‐catenin in ccRCC cells, which further facilitated aerobic glycolysis and immune tolerance of ccRCC. Collectively, our findings display the vital function of NCAPH in ccRCC and uncover that NCAPH may be regarded as a potential therapeutic target to reverse the immune tolerance of ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsAnimalsMiceCell Line, TumorCell ProliferationCell DeathAdenosine TriphosphatasesDNA-Binding ProteinsMultiprotein Complexes

Substanzen

condensin complexesAdenosine TriphosphatasesDNA-Binding ProteinsMultiprotein Complexes

Autor:innen und Institutionen

  • Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Xing Zeng

Förderung

  • Natural Science Foundation of Hubei Province

Zitieren

APA

Chen, Z., Ruan, W., Guo, C., Chen, K., Li, L., Tian, J., Hu, Z., Peng, D., & Zeng, X. (2023). Non‐SMC condensin I complex subunit H participates in anti‐programmed cell death‐1 resistance of clear cell renal cell carcinomas. Cell Proliferation. https://doi.org/10.1111/cpr.13400

Vancouver

Chen Z, Ruan W, Guo C, Chen K, Li L, Tian J, et al. Non‐SMC condensin I complex subunit H participates in anti‐programmed cell death‐1 resistance of clear cell renal cell carcinomas. Cell Proliferation. 2023. doi:10.1111/cpr.13400

BibTeX
@article{Chen2023,
  author = {Chen, Zhi and Ruan, Weiqiang and Guo, Chunhao and Chen, Ke and Li, Le and Tian, Jihua and Hu, Zhiquan and Peng, Dan and Zeng, Xing},
  title = {Non‐SMC condensin I complex subunit H participates in anti‐programmed cell death‐1 resistance of clear cell renal cell carcinomas},
  journal = {Cell Proliferation},
  year = {2023},
  doi = {10.1111/cpr.13400}
}
Kostenlos starten →